Skip to content
Portrait of Asif Menghrani

Independent Board Director

Independent board judgement before strategic options narrow.

Markets, regulation, AI and customer behaviour are changing faster than most boards can reassess. The greater risk is recognising change too late — once assumptions have hardened and options have narrowed.

After three decades leading complex transformation, I help Chairs and boards test strategic assumptions, see material change early and keep sound choices open.

Available for Non-Executive Director appointments

Currently contributing through three advisory boards.

My current advisory-board roles provide ongoing exposure to strategic, technology and governance questions facing organisations navigating change.

These are advisory-board appointments, not statutory Non-Executive Director roles.

What I Bring to a Board

Three lenses applied to board judgement.

What distinguishes the contribution is not sector expertise alone. It is judgement formed through accountability for consequential change — and now applied independently, from outside the executive line.

01

Strategic Judgement

Helping boards distinguish evidence from confidence, test assumptions and improve decisions before commitments become difficult to reverse.

02

Transformation Oversight

Connecting investment, technology and organisational capability to determine whether change is creating intended value.

03

Human Systems Insight

Understanding how culture, incentives and information quality influence decision-making.

Boards navigating complex situations.

I contribute where strategic choices depend on understanding change, uncertainty and the organisation’s ability to execute.

Strategic transformation

AI and technology disruption

Business model reinvention

Organisational capability and change

Complex stakeholder environments

Experience

Three decades applying judgement across complex sectors.

Sectors

  • Banking
  • Pharmaceuticals
  • Professional services
  • Technology-enabled businesses

Selected organisations

  • UBS
  • Novartis
  • PwC
  • Fresenius
  • MCH Group
  • Philips

These organisations are context for the pattern recognition three decades produced — not the argument itself.

Experience is the raw material. Judgement is the contribution.

Available to discuss independent board director mandates and advisory opportunities.